Slide 1 Phase I studies in non-oncology: Dosing & Designs April 18 th 2012 Sharon O’Byrne Senior Medical Director Genentech Research & Early Development Slide 2…

Slide 1 Squire, Sanders & Dempsey L.L.P. www.ssd.com Roadmap to Emerging Regions: Clinical Trials in Developing Countries International Clinical Trials Conference New…

Slide 1 Agenda 3:00 PMIntroduction to Workshop Barry Reisberg, M.D. 3:05 PM Cognitive dynamics: how variability in brain Kenneth Rockwood M.D., FRCPC, FRCP function influences…

Slide 1 New Antiepileptic Medications Drug Profiles, Efficacy, Safety, and Tolerability Evolving Epilepsy Therapy Treatments First-generation AEDs 1930-1980s Second-generation…

A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park, MD, PhD, University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE…

Profile Analysis of Cascade Impactor Data: An Alternative View Andrew R Clark, Ph.D. Orally Inhaled and Nasal Drug Products Subcommittee of the Advisory Committee for Pharmaceutical…

Newer and Future (Device) Therapies for Heart Failure William T. Abraham, MD, FACP, FACC, FAHA, FESC Professor of Medicine, Physiology, and Cell Biology Chair of Excellence…

Dr A. De Simone La terapia di resincronizzazione ed il trapianto in pazienti oncologici Breast. 2004 Jun;13(3):173-83. Cardiotoxicity associated with trastuzumab (Herceptin)…

PowerPoint Presentation March 2013 1 Drug Utilization and the Pharmaceutical Pipeline: Correctional Health Care Formulary Considerations 1 Objectives Overview the drug utilization…

Use of Foreign Data for Approval Ann Farrell, MD Division of Oncology Drug Products Center for Drug Evaluation and Research Food and Drug Administration Disclaimer The views…